loader

World Tenders & Procurement Opportunities

Search
Advanced Search

Awarded - Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 of the German Social Code, Book V (SGB V) for the active ingredient erythropoietin (exclusively epoetin zeta), ATC B03XA01 for the period 01.12.2024 - 30.11.2026 - 459953

World Biggest Tenders Source

This tender with title Awarded - Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 of the German Social Code, Book V (SGB V) for the active ingredient erythropoietin (exclusively epoetin zeta), ATC B03XA01 for the period 01.12.2024 - 30.11.2026 - 459953 has been published on Bidding Source portal dated 08 Jul 2026 for the country of Germany. It has been categorized on Pharmaceutical products. For similar tenders you can see tenders mentioned below of this page.

General Information

Germany

Awarded - Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 of the German Social Code, Book V (SGB V) for the active ingredient erythropoietin (exclusively epoetin zeta), ATC B03XA01 for the period 01.12.2024 - 30.11.2026 - 459953
Contract Award
459953
Germany
8 Jul 2026
English
Pharmaceutical products

For viewing full details of tenders, you should Log in to your account. If not registered yet, Please Register Now

Or Request a call back now and one of our representatives will contact you. Contact us

Similar Tenders

Awarded - Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 of the German Social Code, Book V (SGB V) for the active ingredient erythropoietin, exclusively epoetin alfa, ATC B03XA01, for the period 01.03.2025 - 28.02.2027 - 460626 Germany Pharmaceutical products – Conclusion not excluding drug discount agreement pursuant to Section 130a Paragraph 8 SGB V by way of an open-house model for the active ingredient Eltrombopag (ATC code according to WHO: B02BX05) - 458576 Germany Awarded - Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 of the German Social Code, Book V (SGB V) for the active ingredient etravirine, ATC J05AG04, for the period 01.07.2024 - 30.06.2026 - 459153 Germany Awarded - Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 of the German Social Code, Book V (SGB V) for the active ingredient Ixekizumab, ATC L04AC13, for the period 01.07.2024 - 30.06.2026 - 459071 Germany Pharmaceutical products – Open House Discount Agreements 2026-11 - Dorzolamide ATR (EDO) - 460456 Germany Awarded - Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 of the German Social Code, Book V (SGB V) for the active ingredient axitinib, ATC L01EK01, for the period 01.09.2025 - 31.08.2027 (plus extension option of 1 x 12 months) - 459923 Germany Awarded - Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 of the German Social Code, Book V (SGB V) for the active ingredient dornase alfa, ATC R05CB13, for the period 01.07.2024 - 30.06.2026 - 460579 Germany Awarded - Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 of the German Social Code, Book V (SGB V) for the active ingredient tapendadol (excluding strength 25 mg in the standard pack size N3), ATC N02AX06 fd Z. 01.11.24 - 31.10.26 - 457900 Germany Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 of the German Social Code, Book V (SGB V) for medicinal products containing the active ingredient rivaroxaban (ATC code: B01AF01 - in all strengths except 2.5 mg per unit oral dosage form). - 459069 Germany Awarded - Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 of the German Social Code, Book V (SGB V) for the active ingredient Dasatinib (excluding strength 100 mg in standard sizes N2 and N3, ATC L01EA02, valid from 01.11.24 to 31.10.26). - 458941 Germany
Pharmaceutical products Tenders
Germany Tenders
Europe Tenders
Tenders
No. 12, 1 st floor, Block B2, EGS Business Park, World Trade Center, Bakirkoy - Istanbul - Turkey
info@biddingsource.com
24 X 7 online support
TOP
For viewing latest tenders published for your business in all over the World: Sign in Join free
For accessing full details of Tenders, Kindly choose the Plan that works for you: View Subscription Plans